Sodium Valproate-loaded Nanospanlastics in Patchy Alopecia Areata in Comparison to Topical Steroids
Assessment of Efficacy and Safety of Sodium Valproate -Loaded Nanospanlastics in Patients With Patchy Alopecia Areata in Comparison to Conventional Therapy With Topical Steroids: a Randomized Controlled Study, With Clinical, Dermoscopic and Molecular Asessements
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Completed
- Declared phase
- Early phase 1
- Sponsor
- Kasr El Aini Hospital
- Participants (registry)
- 67
- Start
- May 2021
- Primary completion
- January 2023
- Study completion
- April 2023
- Last registry update
- June 2023
- Countries
- Egypt
Conditions studied: Alopecia Areata
Interventions: the optimized sodium valproate-loaded nanospanlastic dispersion, mometasone furoate lotion
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.